Difference between revisions of "Team:UMaryland/Practices"

Line 194: Line 194:
 
<p style="font-size:18px;text-align:justify;">We met with a researcher who studies, among many things, macular degeneration.
 
<p style="font-size:18px;text-align:justify;">We met with a researcher who studies, among many things, macular degeneration.
  
The first visit was to Wilmer Eye Institute in Baltimore where we spoke to Dr. Noriko Esumi, who studies retinal pigment epithelium (RPE) and how it relates to AMD. After giving her an explanation of what iGEM is and why we were choosing to study lutein production, she told us that, while her experience with lutein itself is limited, she would be more than willing to answer all of our questions. All we had to do was ask what her research involved and it sparked a long, information-rich conversation.  
+
at the Wilmer Eye Institute we spoke to Dr. Noriko Esumi, who studies retinal pigment epithelium (RPE) and how it relates to AMD. After giving her an explanation of what iGEM is and why we were choosing to study lutein production, she told us that, while her experience with lutein itself is limited, she would be more than willing to answer all of our questions. All we had to do was ask what her research involved and it sparked a long, information-rich conversation.  
  
 
From the meeting with Dr. Esumi, We learned the following:
 
From the meeting with Dr. Esumi, We learned the following:

Revision as of 03:55, 16 September 2015